These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 33381588)
41. Tumor associated antigen PRAME is a marker of favorable prognosis in childhood acute myeloid leukemia patients and modifies the expression of S100A4, Hsp 27, p21, IL-8 and IGFBP-2 in vitro and in vivo. Tajeddine N; Louis M; Vermylen C; Gala JL; Tombal B; Gailly P Leuk Lymphoma; 2008 Jun; 49(6):1123-31. PubMed ID: 18452107 [TBL] [Abstract][Full Text] [Related]
42. Clinicopathological significance and prognostic value of the expression of the cancer stem cell marker CD133 in hepatocellular carcinoma: a meta-analysis. Zhong C; Wu JD; Fang MM; Pu LY Tumour Biol; 2015 Sep; 36(10):7623-30. PubMed ID: 25921286 [TBL] [Abstract][Full Text] [Related]
43. Molecular risk prediction in cutaneous melanoma: A meta-analysis of the 31-gene expression profile prognostic test in 1,479 patients. Greenhaw BN; Covington KR; Kurley SJ; Yeniay Y; Cao NA; Plasseraud KM; Cook RW; Hsueh EC; Gastman BR; Wei ML J Am Acad Dermatol; 2020 Sep; 83(3):745-753. PubMed ID: 32229276 [TBL] [Abstract][Full Text] [Related]
44. Prognostic and clinicopathological significance of CXCL1 in cancers: a systematic review and meta-analysis. Zhang Z; Chen Y; Jiang Y; Luo Y; Zhang H; Zhan Y Cancer Biol Ther; 2019; 20(11):1380-1388. PubMed ID: 31387444 [No Abstract] [Full Text] [Related]
45. PRAME Is a Potential Carcinogenic Biomarker that Correlates with Patient Prognosis and Tumor Immunity Based on Pan-Cancer Analysis. Zhao Q; Zhang Z; Wu Y Ann Clin Lab Sci; 2022 Mar; 52(2):185-195. PubMed ID: 35414497 [TBL] [Abstract][Full Text] [Related]
46. Tumor antigen PRAME is a potential therapeutic target of p53 activation in melanoma cells. Lee YK; Heo HH; Kim N; Park UH; Youn H; Moon EY; Kim EJ; Um SJ BMB Rep; 2024 Jun; 57(6):299-304. PubMed ID: 38835116 [TBL] [Abstract][Full Text] [Related]
47. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors. Zhou L; Li Z; Shao X; Yang B; Feng J; Xu L; Teng Y Pathol Res Pract; 2019 Sep; 215(9):152449. PubMed ID: 31378453 [TBL] [Abstract][Full Text] [Related]
48. Prognostic significance of isolated HMB45 or Melan A positive cells in Melanoma sentinel lymph nodes. Satzger I; Völker B; Meier A; Schenck F; Kapp A; Gutzmer R Am J Surg Pathol; 2007 Aug; 31(8):1175-80. PubMed ID: 17667539 [TBL] [Abstract][Full Text] [Related]
49. Cancer testis antigen PRAME: An anti-cancer target with immunomodulatory potential. Naik A; Thomas R; Al-Khadairi G; Bacha R; Hendrickx W; Decock J J Cell Mol Med; 2021 Nov; 25(22):10376-10388. PubMed ID: 34612587 [TBL] [Abstract][Full Text] [Related]
50. Prognostic Implications of PRAME Expression and Clinicopathological Factors in Sinonasal Mucosal Melanoma: A Single-center Cohort Study of 30 Cases. Durzynska M; Dos Santos FLC; Matuszczyk A; Derezinska-Wolek E; Michalek IM Anticancer Res; 2023 Oct; 43(10):4551-4557. PubMed ID: 37772580 [TBL] [Abstract][Full Text] [Related]
51. Clinicopathological and prognostic value of CD24 expression in breast cancer: a meta-analysis. Liu G; Liu GX; Fang Y; Cao ZY; Du HH; Fu J; Qian K Int J Biol Markers; 2017 May; 32(2):e182-e189. PubMed ID: 28315505 [TBL] [Abstract][Full Text] [Related]
52. Evaluation of prognostic value of lncRNA BANCR in tumor patients: A systematic review and meta-analysis. Zhang G; Cai J J BUON; 2019; 24(6):2553-2559. PubMed ID: 31983132 [TBL] [Abstract][Full Text] [Related]
53. PRAME Expression and Its Clinical Relevance in Hodgkin's Lymphoma. Ercolak V; Paydas S; Bagir E; Ergin M; Seydaoglu G; Celik H; Yavu B; Tanriverdi K; Gunaldi M; Afsar CU; Duman BB Acta Haematol; 2015; 134(4):199-207. PubMed ID: 26044287 [TBL] [Abstract][Full Text] [Related]
54. Prognostic value and therapeutic potential of the long noncoding RNA TP73-AS1 in cancers: A systematic review and meta-analysis. Zhong Y; Zhao M; Yu Y; Li Q; Wang F; Wu P; Zhang W; Miao L Sci Rep; 2020 Jun; 10(1):9053. PubMed ID: 32493915 [TBL] [Abstract][Full Text] [Related]
55. Preferentially Expressed Antigen of Melanoma Prevents Lung Cancer Metastasis. Huang Q; Wei H; Wu Z; Li L; Yao L; Sun Z; Li L; Lin Z; Xu W; Han S; Cao W; Xu Y; Song D; Yang X; Xiao J PLoS One; 2016; 11(7):e0149640. PubMed ID: 27391090 [TBL] [Abstract][Full Text] [Related]
56. Prognostic and clinicopathological role of long non-coding RNA UCA1 in various carcinomas. Wang X; Peng F; Cheng L; Yang G; Zhang D; Liu J; Chen X; Zhao S Oncotarget; 2017 Apr; 8(17):28373-28384. PubMed ID: 28423704 [TBL] [Abstract][Full Text] [Related]
57. Prognostic significance of A-kinase interacting protein 1 expression in various cancers: A meta-analysis based on the Chinese population. Xue S; Zhang C; Xu J; Zhou C Medicine (Baltimore); 2022 Jun; 101(25):e29203. PubMed ID: 35758348 [TBL] [Abstract][Full Text] [Related]
58. A meta-analysis on the role of pleiotrophin (PTN) as a prognostic factor in cancer. Zhou J; Yang Y; Zhang Y; Liu H; Dou Q PLoS One; 2018; 13(11):e0207473. PubMed ID: 30427932 [TBL] [Abstract][Full Text] [Related]
59. Prognostic value of periostin in multiple solid cancers: A systematic review with meta-analysis. Yang T; Deng Z; Pan Z; Qian Y; Yao W; Wang J J Cell Physiol; 2020 Mar; 235(3):2800-2808. PubMed ID: 31517399 [TBL] [Abstract][Full Text] [Related]
60. Prognostic and clinicopathological value of Twist expression in breast cancer: A meta-analysis. Qiao W; Jia Z; Liu H; Liu Q; Zhang T; Guo W; Li P; Deng M; Li S PLoS One; 2017; 12(10):e0186191. PubMed ID: 29016671 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]